Submit Manuscript    >>    Login | Register

AF Literature Database


Search Knowledgebase by



Author last name starts with
B. Weijs(4)Asirvatham Samuel J SJ(3)Alan S. Go, MD(3)
Charlotte Eitel, MD(3)Ayman A. Hussein, MD(3)Blanke Philipp P(2)
Anné Wim W(2)Chamberlain AM(2)Berenfeld Omer O(2)
Caputo M(2)Chao TF(2)Chen Peng-Sheng PS(2)
Albert Nancy M NM(2)Andrade JG(2)Akira Fukui, MD(2)
Ajay K Jain(2)Cook G Elliott GE(2)Botto GL(2)
Bokeriia L A LA(2)Casella M(2)Antonio Hernández-Madrid(2)
Christian Sohns(2)Bengt Zöller(2)Badger Troy J TJ(2)
Charlotte Eitel(2)Cao Fei-fei FF(1)Craiglow Brittany B(1)
Biviano Angelo A(1)Cakulev Ivan I(1)Bunch T Jared TJ(1)
Contreras-Valdes FM(1)Alexander Wutzler(1)Boldt Leif-Hendrik LH(1)
Bungard Tammy J TJ(1)Butcher Kenneth K(1)Bonvini R F RF(1)
A. John Camm, MD(1)Alison Beauchamp(1)Barry A(1)
Calvert Patrick A PA(1)Cleland John G F JG(1)Berry Jarett D JD(1)
Al-Khatib Sana M SM(1)Ahmed Humera H(1)Agarwal Shuchita S(1)
Barrett-Connor E(1)Charlotte Warren-Gash(1)Cortez-Dias Nuno N(1)
Babuty D D(1)Clem James R JR(1)


Literature Related to Schotten U [Author]
 <<  <  1 2
  • Post-operative atrial fibrillation: a maze of mechanisms


    Authors : Maesen B; Nijs J; Maessen J; Allessie M;

    Affiliations : 1Department of Cardiothoracic Surgery, University Hospital of Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands. Tel: +31 43 3881077; fax: +3143 3884166, Email: Schotten@maastrichtuniversity.nl

    Journal : Europace   (2011)

    Related Links: Pubmed | Publisher website


  • Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.


    Authors : Kirchhof P; Lip GY; Van Gelder IC; Bax J; Hylek E; Kaab S; Schotten U; Wegscheider K; Boriani G; Brandes A; Ezekowitz M; Diener H; Haegeli L; Heidbuchel H; Lane D; Mont L; Willems S; Dorian P; Aunes-Jansson M; Blomstrom-Lundqvist C; Borentain M; Breitenstein S; Brueckmann M; Cater N; Clemens A; Dobrev D; Dubner S; Edvardsson NG; Friberg L; Goette A; Gulizia M; Hatala R; Horwood J; Szumowski L; Kappenberger L; Kautzner J; Leute A; Lobban T; Meyer R; Millerhagen J; Morgan J; Muenzel F; Nabauer M; Baertels C; Oeff M; Paar D; Polifka J; Ravens U; Rosin L; Stegink W; Steinbeck G; Vardas P; Vincent A; Walter M; Breithardt G;

    Affiliations : University Hospital Münster, Münster, Germany. Corresponding author. Tel: +49 251 8345185; fax: +49 251 8345185, Email: kirchhp@uni-muenster.de

    Journal : Europace   (2011)

    Related Links: Pubmed | Publisher website


  • The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)


    Authors : European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH; ESC Committee for Practice Guidelines, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P;

    Affiliations : St George's University of London, Cranmer Terrace, London SW17 ORE, UK. Tel: +44 20 8725 3414, Fax: +44 20 8725 3416, Email: jcamm@sgul.ac.uk The content of these European Society of Cardiology (ESC) Guidelines has been published for personal and educational use only. No commercial use is authorized. No part of the ESC Guidelines may be translated or reproduced in any form without written permission from the ESC. Permission can be obtained upon submission of a written request to Oxford University Press, the publisher of EP-Europace and the party authorized to handle such permissions on behalf of the ESC.

    Journal : EP Europace   (2011)

    Related Links: Pubmed | Publisher website


  • Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation


    Authors : Linz D; Schotten U; Neuberger HR; Böhm M;

    Affiliations : Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany Address reprint requests and correspondence: Dominik Linz, M.D., Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, 66421 Homburg/Saar, Germany

    Journal : Heart Rhythm   (2011)

    Related Links: Pubmed | Publisher website


  • Atrial Sources of Reactive Oxygen Species Vary With the Duration and Substrate of Atrial Fibrillation


    Authors :

    Affiliations : Correspondence to Barbara Casadei, MD, DPhil, FRCP, Department of Cardiovascular Medicine, University of Oxford, Level 6, West Wing, John Radcliffe Hospital, Oxford, OX3 9DU, UK. E-mail barbara.casadei@cardiov.ox.ac.uk

    Journal : Original Articles   (2011)

    Related Links: Pubmed | Publisher website N/A


  • Atrial Sources of Reactive Oxygen Species Vary With the Duration and Substrate of Atrial Fibrillation


    Authors :

    Affiliations : Correspondence to Barbara Casadei, MD, DPhil, FRCP, Department of Cardiovascular Medicine, University of Oxford, Level 6, West Wing, John Radcliffe Hospital, Oxford, OX3 9DU, UK. E-mail barbara.casadei@cardiov.ox.ac.uk

    Journal : Original Articles   (2011)

    Related Links: Pubmed | Publisher website


  • Transmural Conduction Is the Predominant Mechanism of Breakthrough During Atrial Fibrillation


    Authors :

    Affiliations : Correspondence to Ulrich Schotten, MD, PhD, Department of Physiology, University Maastricht, PO Box 616, 6200 MD Maastricht, The Netherlands. E-mail Schotten@maastrichtuniversity.nl

    Journal : N/A   (2013)

    Related Links: Pubmed | Publisher website


  • Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference


    Authors :

    Affiliations : University of Birmingham Centre for Cardiovascular Sciences and SWBH NHS Trust, Institute for Biomedical Research, 1st Floor, Room 136, Birmingham B15 2TT, UK University Hospital Münster, Münster, Germany AFNET, Germany CHU de Nancy, Nancy, France Duke University School of Medicine, Durham, NC, USA Fondazione Cardiocentro Ticino, Lugano, Switzerland St. Jude Medical, St. Paul, MN, USA Department of Cardiology, University of Leiden Medical Center, Leiden, NL, The Netherlands Department of Cardiology, Institution of Medical Science, Uppsala University, Uppsala, Sweden St. Antonius Hospital, Nieuwegein, The Netherlands University of Bologna, Bologna, Italy Odense University Hospital, Odense, Denmark Meda Pharma SAS, Paris, France University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany The Johns Hopkins Hospital, Baltimore, MD, USA University of Oxford, Oxford, UK University Hospital Maastricht, Maastricht, The Netherlands Daiichi Sankyo Europe GmbH, Munich, Germany University Duisburg-Essen, Essen, Germany Lankenau Institute for Medical Research, Wynnewood, PA, USA CRI—The Clinical Research Institute, Munich, Germany Ludwig Maximilian University, Munich, Germany University of Calgary/Libin, Calgary, Alberta, Canada Garibaldi-Nesima Hospital, Catania, Italy Bristol-Myers Squibb, Munich, Germany University Hospital Zurich, Zurich, Switzerland Faculté de Médecine Pitié-Salpêtrière, Paris, France Charité Berlin, Berlin, Germany University Hospital Gasthuisberg, Leuven, Belgium Hôpital Cardologique du Haut-Lévêque and the Université Victor Segalen Bordeaux II, Bordeaux, France University of Lausanne, Lausanne, Switzerland Institute for Clinical and Experimental Medicine, Prague, Czech Republic Klinik St. Georg, Hanseatisches Herzzentrum, Hamburg, Germany Isar Herzzentrum, Munich, Germany Medtronic International Trading Sàrl, Tolochenaz, Switzerland Hospital Clínic, University of Barcelona, Barcelona, Spain Pfizer Deutschland GmbH, Berlin, Germany Aarhus University Hospital, Aarhus, Denmark Städtisches Klinikum Brandenburg, Brandenburg, Germany Hacettepe University Faculty of Medicine, Ankara, Turkey Medizinische Universität Graz, Graz, Austria University of Belgrade, Belgrade, Serbia TU Dresden, Dresden, Germany Columbia University Medical Center, New York, NY, USA Bristol-Myers Squibb, Rueil-Malmaison, Paris, France Bayer Vital GmbH, Leverkusen, Germany St. Jude Medical, Zaventem, Belgium Boston Scientific, St. Paul, MN, USA Zentrum für Kardiologie am Klinikum Starnberg, Starnberg, Germany Institute of Cardiology, Warsaw, Poland Ettore Sansavini Health Science Foundation, Cotignola, Italy Ospedale dell'Angelo, Mestre-Venice, Venice, Italy Bayer Pharma AG, Berlin, Germany University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Sanofi Aventis Deutschland GmbH, Berlin, Germany University College Hospital, London, UK University Heart Center Hamburg, Hamburg, Germany St. George's Hospital Medical School, London, UK

    Journal : N/A   (2013)

    Related Links: Pubmed | Publisher website


  • Rearrangement of Atrial Bundle Architecture and Consequent Changes in Anisotropy of Conduction Constitute the 3-Dimensional Substrate for Atrial Fibrillation


    Authors :

    Affiliations : From the Department of Physiology, Maastricht University, Maastricht, The Netherlands (B.M., S.Z., J.E., A.v.H., S.V., U.S.); Department of Cardiothoracic Surgery, Maastricht University Hospital, Maastricht, The Netherlands (B.M., J.M.); Department of Engineering Science (C.A.) and Department of Physiology, Anatomy, and Genetics (R.A.B.B., D.T., V.G.), University of Oxford, Oxford, United Kingdom; Department of Medicine, University Hospital Basel, Basel, Switzerland (J.E.); National Heart and Lung Institute, Imperial College, London, United Kingdom (P.K.); and Centre for Advanced Biomedical Imaging, University College London, London, United Kingdom (D.J.S.).

    Journal : N/A   (2013)

    Related Links: Pubmed | Publisher website


  • Transmural Conduction Is the Predominant Mechanism of Breakthrough During Atrial Fibrillation


    Authors :

    Affiliations : From the Department of Physiology, University Maastricht, Maastricht, The Netherlands (J.E., S.Z., D.L., B.M., S.V., A.v.H., M.A.A., U.S.); Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands (H.C.); and Department of Medicine, University Hospital Basel, Basel, Switzerland (J.E.).

    Journal : N/A   (2013)

    Related Links: Pubmed | Publisher website


Biosense Webster
event date
Introduction to AFib
Ablation Specialist

View Ablation Specialists